Holen Sie sich die Stockscreener-App
51.76
0.47%
0.24
Handel nachbörslich:
51.76
Schlusskurs vom Vortag:
$51.52
Offen:
$51.86
24-Stunden-Volumen:
1.29M
Relative Volume:
1.11
Marktkapitalisierung:
$1.49B
Einnahmen:
$915.25M
Nettoeinkommen (Verlust:
$131.14M
KGV:
11.57
EPS:
4.472
Netto-Cashflow:
$96.71M
1W Leistung:
+10.24%
1M Leistung:
+22.42%
6M Leistung:
-47.39%
1J Leistung:
-62.83%
1-Tages-Spanne:
$50.02
$52.51
1-Wochen-Bereich:
$46.47
$52.51
52-Wochen-Spanne:
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
51.76 | 1.49B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc.INSP - PR Newswire
Enterprise value to EBIT forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Inspire Medical Systems (INSP) Faces A Fresh Test As Recalls Put Valuation In Focus - Yahoo Finance
Price to sales forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
ETFs Investing in Inspire Medical Systems, Inc. Stocks - TradingView
2 Reasons INSP is Risky and 1 Stock to Buy Instead - Yahoo Finance
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Understanding Momentum Shifts in (INSP) - Stock Traders Daily
Investors in Inspire Medical Systems, Inc. (INSP): Protect Your RightsContact Levi & Korsinsky Before January 5, 2026 - The National Law Review
Inspire Medical Systems (INSP) Could Be 5% Undervalued After Class II Device Recalls - Sahm
Inspire Medical Systems to report Q2 2026 results on August 3 - scanx.trade
Inspire Medical corrects Q2 2026 results date to Aug. 3 - Stock Titan
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026 - GlobeNewswire
Inspire Medical sets Aug. 3 earnings call after Q2 results - Stock Titan
Inspire Medical Shareholder Alert - TMX Newsfile
Inspire Medical Systems (INSP) Stock Analysis: Navigating the Medical Device Market with a 10% Upside - DirectorsTalk Interviews
Inspire Medical Systems (INSP) Gets a Hold from Wells Fargo - The Globe and Mail
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $56 - Moomoo
Levi & Korsinsky Notifies Inspire Medical Systems, Inc. (INSP) InvestorsLead Plaintiff Deadline on January 5, 2026 - The National Law Review
Inspire Medical Systems (NASDAQ: INSP) D.E. Shaw affiliate reports 5.1% holding - Stock Titan
INSP - Finviz
Inspire Medical Systems CFO departs - MSN
Freedom Capital Markets Initiates Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $62 - Moomoo
INSP Initiates Coverage On Inspire Medical Systems -- Rating Buy - GuruFocus
Inspire Medical shares initiated at buy by Freedom Capital on valuation By Investing.com - Investing.com India
Inspire Medical shares initiated at buy by Freedom Capital on valuation - Investing.com South Africa
Investor Alert: Deadline Approaching to Join Inspire Medical Syst - The National Law Review
Inspire Medical Systems, Inc.(NYSE: INSP) added to Russell 2000 Index - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) dropped from Russell Midcap Growth Benchmark - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) added to Russell 2000 Value Benchmark - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) added to Russell 2000 Growth Benchmark - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) dropped from Russell 1000 Dynamic Index - marketscreener.com
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 11.37% Potential Upside Amidst Mixed Analyst Ratings - DirectorsTalk Interviews
Why Inspire Medical Systems (INSP) Is Up 10.6% After Russell Index Reclassification To Small Cap - simplywall.st
Inspire Medical Systems, Inc.(NYSE: INSP) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) dropped from Russell Midcap Index - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) dropped from Russell 1000 Index - marketscreener.com
Inspire Medical Systems, Inc.(NYSE: INSP) added to Russell 2000 Dynamic Index - marketscreener.com
Inspire Medical Systems, Inc. (INSP) Investigation: Bronstein, Ge - The National Law Review
Inspire Medical Systems | SCHEDULE 13G: Others - Moomoo
Inspire Medical Systems (INSP) On SLEEP 2026 Data Is This A Buying Opportunity Or Priced In - Sahm
Avoiding Lag: Real-Time Signals in (INSP) Movement - Stock Traders Daily
Inspire Medical Systems (INSP) Wells Fargo 2026 MedTech Innovation Spotlight Summary - Quartr
INSP: Inspire V advances clinical outcomes and reimbursement clarity, supporting growth in sleep apnea care - TradingView
INSP: Inspire V advances, coding clarity, and strong clinical data drive growth amid evolving competition - TradingView
Inspire Medical Systems Inc at Wells Fargo MedTech Innovation Spotlight Transcript - GuruFocus
Inspire Medical Systems (INSP) shares June 26, 2026 investor presentation via 8-K - Stock Titan
Inspire Medical Systems, Inc. Actuals & Estimates (NYSE:INSP) - TradingView
INSP Forecast — Price Target — Prediction for 2027 - TradingView
Inspire Medical Systems (INSP) Short Interest & Short Float | Updated Jun 2026 $INSP - MarketBeat
INSP Downgraded by Evercore ISI Group -- Price Target Lowered to $40 - GuruFocus
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):